Johanna Mercier
Net Worth

Last updated:

What is Johanna Mercier net worth?

The estimated net worth of Ms. Johanna Mercier is at least $38,252,710 as of 10 Dec 2024. She owns shares worth $8,599,735 as insider, has earned $5,352,975 from insider trading and has received compensation worth at least $24,300,000 in Gilead Sciences, Inc..

What is the salary of Johanna Mercier?

Ms. Johanna Mercier salary is $4,860,000 per year as Chief Commercial Officer in Gilead Sciences, Inc..

How old is Johanna Mercier?

Ms. Johanna Mercier is 55 years old, born in 1970.

What stocks does Johanna Mercier currently own?

As insider, Ms. Johanna Mercier owns shares in one company:

Company Title Shares Price per share Total value
Gilead Sciences, Inc. (GILD) Chief Commercial Officer 73,127 $117.6 $8,599,735

What does Gilead Sciences, Inc. do?

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Gadeta B.V.; Bristol-Myers Squibb Company; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.

GILD logo
GILD
Gilead Sciences, Inc.
$117.6

Johanna Mercier insider trading

Gilead Sciences, Inc.

Ms. Johanna Mercier has made 6 insider trades between 2020-2024, according to the Form 4 filled with the SEC.

The largest trade she's ever made was exercising 19,496 units of GILD stock on 4 May 2021. As of 10 Dec 2024 she still owns at least 73,127 units of GILD stock.

Transaction Date Security Shares Price per share Total value Source
Option
Restricted Stock Unit 3,752 N/A N/A
Option
Common Stock 3,752 N/A N/A
Sale
Common Stock 5,000 $91.28 $456,400
Sale
Common Stock 15,925 $84.23 $1,341,363
Sale
Common Stock 13,432 $83.25 $1,118,214
Option
Restricted Stock Unit 3,752 N/A N/A
Option
Common Stock 3,752 N/A N/A
Sale
Common Stock 9,513 $78.03 $742,299
Sale
Common Stock 5,490 $73.98 $406,150
Option
Restricted Stock Unit 3,751 N/A N/A
Option
Common Stock 3,751 N/A N/A
Option
Restricted Stock Unit 3,025 N/A N/A
Option
Common Stock 3,025 N/A N/A
Option
Common Stock 6,819 N/A N/A
Option
Restricted Stock Unit 6,819 N/A N/A
Option
Restricted Stock Unit 2,730 N/A N/A
Option
Common Stock 2,730 N/A N/A
Option
Restricted Stock Unit 2,730 N/A N/A
Option
Common Stock 2,730 N/A N/A
Option
Common Stock 7,505 N/A N/A
Option
Restricted Stock Unit 7,505 N/A N/A
Option
Common Stock 2,730 N/A N/A
Option
Restricted Stock Unit 2,730 N/A N/A
Option
Common Stock 7,951 N/A N/A
Option
Restricted Stock Unit 3,025 N/A N/A
Option
Restricted Stock Unit 7,951 N/A N/A
Option
Common Stock 3,025 N/A N/A
Option
Common Stock 990 N/A N/A
Option
Restricted Stock Unit 990 N/A N/A
Option
Restricted Stock Unit 990 N/A N/A
Option
Common Stock 990 N/A N/A
Option
Restricted Stock Unit 7,505 N/A N/A
Option
Common Stock 7,505 N/A N/A
Option
Restricted Stock Unit 990 N/A N/A
Option
Common Stock 990 N/A N/A
Option
Restricted Stock Unit 3,025 N/A N/A
Option
Common Stock 3,962 N/A N/A
Option
Common Stock 3,025 N/A N/A
Option
Restricted Stock Unit 3,962 N/A N/A
Option
Common Stock 7,505 N/A N/A
Option
Restricted Stock Unit 7,505 N/A N/A
Sale
Common Stock 19,496 $66.09 $1,288,549
Option
Common Stock 3,025 N/A N/A
Option
Restricted Stock Unit 3,025 N/A N/A
Option
Restricted Stock Unit 7,505 N/A N/A
Option
Common Stock 7,505 N/A N/A

Gilead Sciences key executives

Gilead Sciences, Inc. executives and other stock owners filed with the SEC: